Not applicableStudy completedNCT02071290What this trial is testingEffect of Remote Ischemic Conditioning on Trauma Patients With Hemorrhagic ShockWho this might be right forHemorrhagic Shock Unity Health Toronto 50
Not applicableUnknownNCT04192578What this trial is testingEffect of RIC on 2,3-BPG in Erythrocyte (RIC-BPG)Who this might be right for2,3-Bisphosphoglycerate Capital Medical University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06911385What this trial is testingAugmenting Cerebral Blood Flow in Acute Ischemic StrokeWho this might be right forStroke University of Alberta 150
Early research (Phase 1)Study completedNCT01527838What this trial is testingSingle Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood UnitWho this might be right forNon-Hodgkin's Lymphoma (NHL)Hodgkin's DiseaseChronic Lymphocytic Leukemia (CLL)+2 more Fate Therapeutics 10
Testing effectiveness (Phase 2)Study completedNCT00104858What this trial is testingFludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more Fred Hutchinson Cancer Center 66
Not applicableUnknownNCT02631785What this trial is testingFear Conditioning, Extinction and Its Recall in Anxious YouthWho this might be right forPediatric Anxiety Disorders University of Haifa 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262843What this trial is testingTotal Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+1 more City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00020176What this trial is testingAllogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast CancerWho this might be right forBreast Cancer National Cancer Institute (NCI)
Early research (Phase 1)Temporarily pausedNCT00664196What this trial is testingTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningWho this might be right forProstate Cancer Roger Williams Medical Center 18
Testing effectiveness (Phase 2)WithdrawnNCT02715505What this trial is testingSafety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)Who this might be right forInherited Metabolic Disorders IMD Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02988466What this trial is testingReduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCTWho this might be right forHematologic Malignancies Masonic Cancer Center, University of Minnesota 78
Testing effectiveness (Phase 2)Study completedNCT03159702What this trial is testingPropylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical TransplantationWho this might be right forHematological MalignancyMultiple Myeloma Medical College of Wisconsin 43
Not applicableStudy completedNCT02089529What this trial is testingTreatment of Axial Spondyloarthritis With Reduced Doses of NSAIDsWho this might be right forAxial Spondyloarthritis University Hospital of North Norway 8
Testing effectiveness (Phase 2)Looking for participantsNCT02859402What this trial is testingAllogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell LymphomasWho this might be right forT-cell Non-Hodgkin LymphomaLymphoma, Extranodal NK-T-Cell Keimyung University Dongsan Medical Center 34
Large-scale testing (Phase 3)Enrolling By InvitationNCT05674539What this trial is testingReduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic SyndromeWho this might be right forAcute Myeloid Leukemia, AdultMyelodysplastic Syndrome(MDS)Allogeneic Hematopoietic Stem Cell Transplantation Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200
Testing effectiveness (Phase 2)Study completedNCT00923195What this trial is testingRadiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic MelanomaWho this might be right forMelanomaSkin Cancer National Cancer Institute (NCI) 4
Post-approval studies (Phase 4)Looking for participantsNCT07101588What this trial is testingRuxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized TrialWho this might be right forAllogeneic Hematopoietic Stem Cell Transplantation (HSCT) Chinese PLA General Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06471946What this trial is testingVA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDSWho this might be right forHigher-risk Myelodysplastic Syndromes Navy General Hospital, Beijing 54
Testing effectiveness (Phase 2)UnknownNCT02507479What this trial is testingThiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid MalignanciesWho this might be right forNon Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic Leukemia+1 more Sheba Medical Center 24
Not applicableLooking for participantsNCT06350786What this trial is testingConditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Chronic Non-cancer PainWho this might be right forChronic Non-cancer Pain Cosima Locher 86